Patients in the lowest quartile of mtDNA copy numbers had a 3.43‐fold (95% CI 1.24–9.50, P = 0.018) higher risk for cancer mortality compared with those in quartiles 2–4 (data adjusted for age, smoking status, CRP, prevalent CVD and diabetes). Here, CRP is linked to cancer.